The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In VivoZheng‐Wei Lee, Lih‐Wen Deng, Chien-Shing Chen et al.|PLoS ONE|2011Cited by 379
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Wee Joo Chng|Blood|2011Cited by 212
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaJianbiao Zhou, Wee Joo Chng|Journal of Hematology & Oncology|2017Cited by 75
PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML TherapyJianbiao Zhou, Chien Shing Chen|PLoS ONE|2011Cited by 65
A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseJianbiao Zhou, Wee Joo Chng|Journal of Hematology & Oncology|2018Cited by 39